Changes in insulin receptor functions of the erythrocyte by treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients with glibenclamide and diet control
- PMID: 3098013
- DOI: 10.1007/BF02624709
Changes in insulin receptor functions of the erythrocyte by treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients with glibenclamide and diet control
Abstract
The insulin binding of erythrocytes from: (i) fifteen age-matched normal subjects, (ii) ten untreated NIDDM patients and (iii) fifteen treated (glibenclamide + hypocaloric diet) NIDDM patients (all males) has been studied. A significant decrease in specific insulin binding was observed in group (ii) which improved in cases controlled after treatment (group iii). Scatchard analysis of the results suggested that changes in insulin binding were due to alteration in the number of insulin receptors on erythrocytes. The number of insulin receptors/cell was 471 in normals, 160 in diabetics and 282 in treated diabetic subjects. No significant change in the binding affinity was observed in the three groups (1.0 X 10(8), 1.2 X 10(8) and 1.1 X 10(8) M-1 in normal subjects, untreated diabetics and treated diabetics, respectively).
Similar articles
-
Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy.Acta Diabetol Lat. 1988 Jul-Sep;25(3):205-14. doi: 10.1007/BF02624815. Acta Diabetol Lat. 1988. PMID: 3149105
-
Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.Klin Wochenschr. 1984 Jul 2;62(13):631-9. doi: 10.1007/BF01721918. Klin Wochenschr. 1984. PMID: 6434794 Clinical Trial.
-
Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.Diabete Metab. 1986 Aug;12(4):219-24. Diabete Metab. 1986. PMID: 3533670 Clinical Trial.
-
Comparative effects of diet or glibenclamide on insulin secretion and action in non-obese NIDDM.Diabetes Res Clin Pract. 1991 Feb;11(2):99-106. doi: 10.1016/0168-8227(91)90098-x. Diabetes Res Clin Pract. 1991. PMID: 1902411 Clinical Trial.
-
The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus.Braz J Med Biol Res. 1988;21(1):35-42. Braz J Med Biol Res. 1988. PMID: 3140992 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical